Constellation Energy heads into July with its sharpest month-long selloff in recent memory — down 14% over 30 days and 8% on the week to $248.37 — just as a cluster of analyst target cuts confirms the Street is ratcheting back expectations ahead of August earnings.
The analyst reset is the week's defining story. Citigroup's Ryan Levine cut his target from $348 to $297 on July 1 — a 15% reduction while maintaining Neutral — following Goldman Sachs initiating coverage at $305 (Neutral) on June 18 and Bernstein starting at $296 (Outperform) the same week. The direction is consistent: even new coverage is landing well below where the stock traded just weeks ago. The consensus mean target of $358 implies roughly 44% upside from current levels, but that figure is weighted by older, more optimistic targets from firms like Scotiabank ($441) and TD Cowen ($381) that have not been refreshed since April and May. The more recent initiations from Goldman and Bernstein, both anchored around $296–$305, suggest the marginal buyer on the Street is pricing the stock closer to current levels than the headline consensus implies.
Options positioning reinforces the cautious tone. The put/call ratio has climbed to 1.41, above its 20-day average of 1.37 — not at an extreme, but tracking in the direction of more defensive hedging. The 52-week high on PCR was 1.69, so there is room for further deterioration. What is notable is the contrast with late April and early May, when the PCR briefly exceeded 1.58 and the stock was already weakening; it has since come back in, but Monday's reading is the highest it has been in a month. Combined with the price action, options traders look cautious rather than panicked.
Short interest is building, though it remains well short of crowded. Shorts have grown roughly 5% week-on-week to 3.76% of the free float — a steady, orderly increase rather than an aggressive pile-on. The borrow cost jumped 84% on the week to 0.72%, which sounds dramatic but remains low in absolute terms; this is a stock that has historically been easy to borrow. Availability is extremely loose at 1,685% — meaning there are roughly 17 shares available to lend for every one currently borrowed — so the supply side of the trade imposes no constraint. The short score of 37 reflects that the setup is not structurally charged; this is more a directional trade on sentiment than a squeeze-prone situation.
The fundamental debate is real. Bulls point to a visible EPS ramp — forecasts climb from $12.75 in 2027 to $16.43 by 2030 — underpinned by nuclear production tax credits rolling off mid-2027 and favorable power auction outcomes. Factor scores back this up: CEG ranks in the 92nd percentile on EPS surprise and 98th on analyst recommendation divergence, suggesting a history of beating estimates even as consensus expectations shift. The bear case centers on execution: declining commodity prices, rising operations and maintenance costs, and uncertainty around large hyperscaler load deals that have been slower to materialise. The PE has compressed to around 21x, down roughly 2.3 turns over the past 30 days, which marks a meaningful de-rating but still leaves the stock priced for a growth story it now needs to re-earn.
The next substantive test is Q2 earnings, scheduled for August 6. The last two prints each produced a down day — off 3.3% and 5.9% respectively — with five-day losses of 14% and 15% following both. With the stock already down 14% this month, the market's patience for another miss or cautious guide will be tested quickly.
See the live data behind this article on ORTEX.
Open CEG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
